Ben Atcliffe
Senior Commercialisation Manager at UniSA Ventures Pty Ltd- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
UniSA Ventures
-
Australia
-
Research
-
1 - 100 Employee
-
Senior Commercialisation Manager
-
Jan 2016 - Present
Adelaide, Australia IP management, Technology Transfer (Licencing, Spin-out company establishment & investment) in Health Science, Pharmacy, Biotech & Medtech. Following companies: Ankere Therapeutics (Board Observer); Brandon BioCatalyst/IPGroup, Cincera Therapeutics (Board Observer); Brandon BioCatalyst, MPI Biotech (Business Management - CUREator), DesmoX Tech (Business Management - CUREator), AbRegen (previous Management Consultant/Board/Capital), Ferronova (previous Capital), Envision Sciences (IP)… Show more IP management, Technology Transfer (Licencing, Spin-out company establishment & investment) in Health Science, Pharmacy, Biotech & Medtech. Following companies: Ankere Therapeutics (Board Observer); Brandon BioCatalyst/IPGroup, Cincera Therapeutics (Board Observer); Brandon BioCatalyst, MPI Biotech (Business Management - CUREator), DesmoX Tech (Business Management - CUREator), AbRegen (previous Management Consultant/Board/Capital), Ferronova (previous Capital), Envision Sciences (IP), Carina Biotech. Supporting: The 'Centre for Cancer Biology' and the 'Future Industries Institute' www.unisa.edu.au/ventures Show less
-
-
-
Pfizer
-
United States
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Project Manager
-
Feb 2015 - Jan 2016
Adelaide, Australia Hospira was acquired by Pfizer in 2015 Pharmaceutical Manufacture - 'Biosimilars' with One to One Contract Manufacture. # I was also involved managing teams from Quality (Validation), Production & Engineering as part of the site upgrade project. Cross functional dealings included construction project team, Quality Systems and Manufacturing Quality.
-
-
-
-
Business Consultant
-
Oct 2013 - Jan 2015
Perth, Australia Consulting Activities: Contracting R&D Tax Project Manager - ROCG Perth (Insight Business Partners) - May 2014 to Jan 2015. > $3 Million R&D Tax Offsets to clients. Experienced in Overseas and Advanced Findings; > $8 Million Successful R&D spend approvals. Clients from Oil & Gas, software to Industrial Design amongst many. OzStar Therapeutics - WA Investment and Market Support - Commercialisation Australia Proof of concept grant - $250k an Agribusiness - Dairy Business… Show more Consulting Activities: Contracting R&D Tax Project Manager - ROCG Perth (Insight Business Partners) - May 2014 to Jan 2015. > $3 Million R&D Tax Offsets to clients. Experienced in Overseas and Advanced Findings; > $8 Million Successful R&D spend approvals. Clients from Oil & Gas, software to Industrial Design amongst many. OzStar Therapeutics - WA Investment and Market Support - Commercialisation Australia Proof of concept grant - $250k an Agribusiness - Dairy Business technologies and Products Biologica Ventures Various Peptide Technologies Show less
-
-
-
Proteomics International
-
Australia
-
Medical Device
-
1 - 100 Employee
-
General Manager
-
Dec 2008 - Oct 2013
Perth, Australia A contract services & R&D company focusing on analysis of Biosimilar & Biologic Drugs and protein Biomarkers. My roles include International Business Development (including managing sales teams in India, Singapore, Malaysia and Japan), Commercialisation, Project Management (eg. Biomarker Diagnostics), IP Management. I recently played a significant role in PI's successful Early Stage Commercialisation grant from Commercialisation Australia to develop a test in Diabetic Kidney… Show more A contract services & R&D company focusing on analysis of Biosimilar & Biologic Drugs and protein Biomarkers. My roles include International Business Development (including managing sales teams in India, Singapore, Malaysia and Japan), Commercialisation, Project Management (eg. Biomarker Diagnostics), IP Management. I recently played a significant role in PI's successful Early Stage Commercialisation grant from Commercialisation Australia to develop a test in Diabetic Kidney Disease (Nephropathy) http://www.commercialisationaustralia.gov.au/OurParticipants/Pages/Proteomics%20International%20Pty%20Ltd.aspx 'PromarkerD' - world leading predictive diagnostic test for diabetic kidney disease Show less
-
-
-
PYC Therapeutics (ASX: PYC)
-
United States
-
Biotechnology
-
1 - 100 Employee
-
Senior Scientist (Head of Protein Chemistry) and Drug Development Manager
-
Sep 2006 - Oct 2008
Perth, Australia Phylogica is an Australian ASX listed Biotech. As a peptide Drug Discovery Company Phylogica uses phage display to screen diverse in-house peptide libraries against medically relevant targets. My roles: Peptide Drug Discovery/Validation and Preclinical Drug Development
-
-
-
-
Senior Tutor/Coordinator of BioMedical Science
-
2004 - 2006
-
-
-
Beckman Coulter Diagnostics
-
United States
-
Medical Equipment Manufacturing
-
700 & Above Employee
-
Consultant
-
2000 - 2006
Technical Consultant to Beckman Coulter in Australia. Presales support; Site commissioning of Microcal (ITC,DSC); Equipment validation; Technical Training and follow-up support.
-
-
Education
-
Bio21 Institute/University of Melbourne
PhD, Protein Biochemistry/Biophysics -
Murdoch University
Masters of Business Administration -
Young Achievement Australia - Biotechnology Entrepreneur Program
-
University of Melbourne
BSc (Hons), Majoring in Biochemistry and Pathology -
Marcellin College
Secondary School -
QUT (Queensland University of Technology)
The Bridge Program